Drug Shortage Report for CLADRIBINE INJECTION
Report ID | 217270 |
Drug Identification Number | 02494574 |
Brand name | CLADRIBINE INJECTION |
Common or Proper name | CLADRIBINE INJECTION |
Company Name | GENERIC MEDICAL PARTNERS INC |
Market Status | MARKETED |
Active Ingredient(s) | CLADRIBINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1mg/ml 10ml Vial |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-01-25 |
Actual start date | 2024-01-25 |
Estimated end date | 2024-02-15 |
Actual end date | 2024-02-26 |
Shortage status | Resolved |
Updated date | 2024-02-27 |
Company comments | Cladribine Injection 1mg/ml 10 ml vial UPC 870573001434 is now available. It is not on allocation. Normal demand levels can be supplied. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-02-27 | English | Compare |
v6 | 2024-02-26 | English | Compare |
v5 | 2024-02-26 | French | Compare |
v4 | 2024-02-26 | English | Compare |
v3 | 2024-01-26 | English | Compare |
v2 | 2024-01-25 | French | Compare |
v1 | 2024-01-25 | English | Compare |
Showing 1 to 7 of 7